These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 22759630)

  • 21. Duration of anticoagulant therapy for patients with venous thromboembolism.
    Garcia D
    Thromb Res; 2008; 123 Suppl 1():S62-4. PubMed ID: 18823648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism.
    Wåhlander K; Eriksson H; Lundström T; Billing Clason S; Wall U; Nyström P; Wessman P; Schulman S;
    Br J Haematol; 2006 Apr; 133(1):68-77. PubMed ID: 16512831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral contraception in women with mild thrombophilia: what have we learned recently?
    Blanco-Molina Á
    Thromb Res; 2012 Oct; 130 Suppl 1():S16-8. PubMed ID: 23026651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.
    Kovac M; Mikovic D; Antonijevic N; Rakicevic L; Djordjevic V; Radojkovic D; Elezovic I
    J Thromb Thrombolysis; 2008 Jun; 25(3):284-7. PubMed ID: 17549437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband.
    Rossi E; Ciminello A; Za T; Betti S; Leone G; De Stefano V
    Thromb Haemost; 2011 Oct; 106(4):646-54. PubMed ID: 21833444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of inherited thrombophilia: guide for genetics professionals.
    Varga EA; Kujovich JL
    Clin Genet; 2012 Jan; 81(1):7-17. PubMed ID: 21707594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.
    Grifoni E; Marcucci R; Ciuti G; Cenci C; Poli D; Mannini L; Liotta AA; Miniati M; Abbate R; Prisco D
    Semin Thromb Hemost; 2012 Mar; 38(2):230-4. PubMed ID: 22422337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [No indication for thrombophilia screening in patients with idiopathic venous thromboembolism and their relatives].
    Middeldorp S; Prins MH; Büller HR
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1047-51. PubMed ID: 11414164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombophilia testing patterns amongst patients with acute venous thromboembolism.
    Meyer MR; Witt DM; Delate T; Johnson SG; Fang M; Go A; Clark NP
    Thromb Res; 2015 Dec; 136(6):1160-4. PubMed ID: 26477821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombophilia evaluation in pulmonary embolism.
    Stern RM; Al-Samkari H; Connors JM
    Curr Opin Cardiol; 2019 Nov; 34(6):603-609. PubMed ID: 31389825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombophilia and pregnancy].
    Carlizza A
    Minerva Cardioangiol; 2006 Dec; 54(6):799-801. PubMed ID: 17393610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the geneticist in testing and counseling for inherited thrombophilia.
    Reich LM; Bower M; Key NS
    Genet Med; 2003; 5(3):133-43. PubMed ID: 12792420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Optimum duration of anticoagulant treatment after an episode of venous thromboembolism].
    Couturaud F; Kearon C
    Rev Pneumol Clin; 2008 Dec; 64(6):305-15. PubMed ID: 19084210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry.
    Roldan V; Lecumberri R; Muñoz-Torrero JF; Vicente V; Rocha E; Brenner B; Monreal M;
    Thromb Res; 2009 Jun; 124(2):174-7. PubMed ID: 19101711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-vitamin K antagonist oral anticoagulants in patients with severe inherited thrombophilia: a series of 33 patients.
    Undas A; Goralczyk T
    Blood Coagul Fibrinolysis; 2017 Sep; 28(6):438-442. PubMed ID: 28079536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does thrombophilia testing help in the clinical management of patients?
    Middeldorp S; van Hylckama Vlieg A
    Br J Haematol; 2008 Nov; 143(3):321-35. PubMed ID: 18710381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.